Clinical Efficacy of Allergen-Specific Immunotherapy from Patient and Physician Perspectives.
The objective of a new study published in the Yonsei Medical Journal was to explore patient and physician perspectives on allergen-specific immunotherapy (AIT) through a questionnaire survey.In this study, allergic patients who received subcutaneous immunotherapy for at least one year participated in a questionnaire developed by an expert panel of allergen and immunotherapy workgroup in Korea.Overall, 267 patients—adults 60.3%; with allergic rhinitis 91.4%; asthma 42.7%; or atopic dermatitis 20.2%
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies